Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor

被引:70
作者
Wu, KK [1 ]
Wu, TJ [1 ]
Chin, J [1 ]
Mitnaul, LJ [1 ]
Hernandez, M [1 ]
Cai, TQ [1 ]
Ren, N [1 ]
Waters, MG [1 ]
Wright, SD [1 ]
Cheng, K [1 ]
机构
[1] Merck Res Labs, Dept Cardiovasc Dis, Rahway, NJ 07065 USA
关键词
atherosclerosis; type; 2; diabetes; insulin resistant; ApoE-/-; db/db; dyslipidemia; hyperglycemia; fenofibrate;
D O I
10.1016/j.atherosclerosis.2005.01.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus is one of the major risk factors associated with atherosclerosis and coronary heart disease but the mechanistic links between the disease and atherosclerosis are not well understood. In this study, we investigated the effect of the deletion of the long-form leptin receptor on the progression of atherosclerosis in ApoE-/- mouse. ApoE-/-;db/db double knockout mice as well as ApoE-/-;db/+ and ApoE-/- littermates were generated by crossing ApoE-/- and db/+ mice. On a regular chow diet, ApoE-/-;db/db mice at 20 weeks of age exhibited features typical of type 2 diabetes: obesity, hyperglycemia, hyperinsulinemia and dyslipidemia and had significantly accelerated atherosclerosis compared with their age-matched ApoE-/- littermates as assessed by either the percentage of the aorta bearing lesion (5.3 +/- 0.9% for ApoE-/-;db/db versus 1.5 +/- 0.5% for ApoE-/-) or by aortic lipid content (similar to 1.5-2-fold increase in free cholesterol and similar to 3-4-fold increase in cholesteryl ester). The atherosclerosis in these ApoE-/-;db/db mice was further accelerated by feeding mice with a Western diet and markedly inhibited by fenofibrate with a 2.5- and 5.3-fold reduction of the lesion in male and female mice, respectively. The results from this study demonstrate that type 2 diabetes can accelerate atherogenesis in mice. This mouse model may provide insight into the mechanistic link between type 2 diabetes and atherosclerosis as well as serve as a valuable tool for evaluating therapeutics. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 32 条
[1]   Effect of leptin on arterial thrombosis following vascular injury in mice [J].
Bodary, PF ;
Westrick, RJ ;
Wickenheiser, KJ ;
Shen, YC ;
Eitzman, DT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (13) :1706-1709
[2]   LRP: Role in vascular wall integrity and protection from atherosclerosis [J].
Boucher, P ;
Gotthardt, M ;
Li, WP ;
Anderson, RGW ;
Herz, J .
SCIENCE, 2003, 300 (5617) :329-332
[3]   Mouse models of atherosclerosis [J].
Breslow, JL .
SCIENCE, 1996, 272 (5262) :685-688
[4]   PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway [J].
Chinetti, G ;
Lestavel, S ;
Bocher, V ;
Remaley, AT ;
Neve, B ;
Torra, IP ;
Teissier, E ;
Minnich, A ;
Jaye, M ;
Duverger, N ;
Brewer, HB ;
Fruchart, JC ;
Clavey, V ;
Staels, B .
NATURE MEDICINE, 2001, 7 (01) :53-58
[5]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]   Peroxisome proliferator-activated receptors in inflammation control [J].
Delerive, P ;
Fruchart, JC ;
Staels, B .
JOURNAL OF ENDOCRINOLOGY, 2001, 169 (03) :453-459
[7]   Reduction of atherosclerosis by the peroxisome proliferator-activated receptor α agonist fenofibrate in mice [J].
Duez, H ;
Chao, YS ;
Hernandez, M ;
Torpier, G ;
Poulain, P ;
Mundt, S ;
Mallat, Z ;
Teissier, E ;
Burton, CA ;
Tedgui, A ;
Fruchart, JC ;
Fiévet, C ;
Wright, SD ;
Staels, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) :48051-48057
[8]   Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease [J].
Eckel, RH ;
Barouch, WW ;
Ershow, AG .
CIRCULATION, 2002, 105 (24) :2923-2928
[9]   Mouse models of hyperlipidemia and atherosclerosis [J].
Fazio, S ;
Linton, MF .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2001, 6 :D515-D525
[10]   Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients [J].
Forcheron, F ;
Cachefo, A ;
Thevenon, S ;
Pinteur, C ;
Beylot, M .
DIABETES, 2002, 51 (12) :3486-3491